KYOBO 11 SPECIAL PURPOSE ACQUISITION COMPANY Inactive Instrument
Calendar Kyobo 11 Special Purpose Acquisition Company Korea S.E.
Equities
A397880
KR7397880006
Chart calendar Kyobo 11 Special Purpose Acquisition Company
bbfa2ea6.5_ueGtEWqGoAoenXtuWNvIRU1EEilN4IvxjEVsCu738.trD8QOVT_x03_oi5zIr77dA47DhN-a1-h2q2F63j2E_Xqu5poEz9MkPWmg~6251d444b89bb671d73538630f6cc910
Upcoming events on Kyobo 11 Special Purpose Acquisition Company
No events available
Past events on Kyobo 11 Special Purpose Acquisition Company
| 02/05/2024 | Q1 2024 Earnings Release |
| 26/03/2024 | Q4 2023 Earnings Release |
| 11/07/2024 07:00 | BONESUPPORT HOLDING AB: Q2 2024 Earnings Release |
| 15/07/2024 | SWEDISH ORPHAN BIOVITRUM AB: Q2 2024 Earnings Release |
| 23/07/2024 07:00 | BIOGAIA AB: Q2 2024 Earnings Release |
| 23/07/2024 | SAMSUNG BIOLOGICS CO.,LTD.: Q2 2024 Earnings Release (Projected) |
| 24/07/2024 | PHARMA MAR, S.A.: Q2 2024 Earnings Release (Projected) |
| 24/07/2024 | GRIFOLS, S.A.: Q2 2024 Earnings Release (Projected) |
| 25/07/2024 06:00 | UCB: Q2 2024 Earnings Release |
| 25/07/2024 | SK BIOSCIENCE CO.,LTD.: Q2 2024 Earnings Release (Projected) |
| 29/07/2024 | BIOMARIN PHARMACEUTICAL INC.: Q2 2024 Earnings Release (Projected) |
| 29/07/2024 | INCYTE CORPORATION: Q2 2024 Earnings Release (Projected) |
Past sector events for Kyobo 11 Special Purpose Acquisition Company
| 23/05/2024 10:43 | CONCORD BIOTECH LIMITED: Q4 2024 Earnings Release |
| 14/05/2024 16:35 | GRIFOLS, S.A.: Q1 2024 Earnings Release |
| 13/05/2024 | NATURECELL CO.,LTD.: Q1 2024 Earnings Release |
| 09/05/2024 | PHARMARESEARCH CO., LTD.: Q1 2024 Earnings Release |
| 09/05/2024 | MEDY-TOX INC.: Q1 2024 Earnings Release |
| 09/05/2024 21:05 | AVIDITY BIOSCIENCES, INC.: Q1 2024 Earnings Release |
| 09/05/2024 21:05 | ADMA BIOLOGICS, INC.: Q1 2024 Earnings Release |
| 09/05/2024 07:30 | NXERA PHARMA CO., LTD.: Q1 2024 Earnings Release |
| 08/05/2024 | HUGEL, INC.: Q1 2024 Earnings Release |
| 08/05/2024 21:16 | CATALYST PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
